SurModics buys Brookwood Pharma for up to $62M
SurModics, a publicly traded medical-device maker, agreed to acquire Birmingham, Ala.’s Brookwood Pharmaceuticals for $40 million in cash plus milestone payments of up to $22 million. Brookwood develops polymer-based drug formulations. Bloomberg has more here.
Next Story: Juvaris Bio wins $9M grant for flu-vaccine adjuvants
Previous Story: AlphaMed Pharma raising $50M for recombinant alpha-1 antitrypsin
About the Author, David P. Hamilton
David Hamilton has been writing for VentureBeat LifeScience since April 2007. He formerly spent 14 years as a reporter for the Wall Street Journal in its San Francisco and Tokyo bureaus. Prior to that, he spent several years as a reporter at Science Magazine and as a reporter/researcher for the New Republic, both in Washington.
